
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy
2021年5月4日 · Kuur Therapeutics (formerly known as Cell Medica) is a clinical-stage biopharmaceutical company focused on the development of off-the-shelf CAR-NKT cell immunotherapies for the treatment of solid...
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy ...
2021年5月4日 · “Kuur’s innovative technology, combined with our TCR program, could propel us into a leadership position in cell therapy. This platform also has the potential to provide synergies with other ...
Kuur Therapeutics Announces Interim Clinical Data Supporting ...
2021年1月21日 · Kuur Therapeutics is a clinical-stage biopharmaceutical company focused on the development of off-the-shelf CAR-NKT cell immunotherapies for the treatment of solid and hematological...
Kuur Therapeutics - LinkedIn
Kuur Therapeutics | 4,651 followers on LinkedIn. Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell...
Cell Medica rebrands as Kuur, raises cash for CAR-NKT trials
2020年3月11日 · Now, Cell Medica has formalized its transformation by rebranding as Kuur and shifting its base from London to Houston. Kuur has received funding to support its next steps.
KUUR Dubai Physiotherapy Center
KUUR Dubai has a dedicated and highly experienced team of western physiotherapists who offer a broad spectrum of proven and evidence based treatments. Our approach to physiotherapy is highly individual, creating a unique treatment program for every patient while delivering results in the shortest possible time.
Athenex Buys Kuur Therapeutics - Quick Facts - Nasdaq
2021年5月5日 · (RTTNews) - Athenex, Inc. (ATNX) has acquired Kuur Therapeutics, Inc., a developer of off-the-shelf CAR-NKT cell immunotherapies for the treatment of solid and hematological malignancies.